A kind of synthesis method of Verdinexor (KPT-335) and its hydrochloride

By performing the acylation reaction in a mixed solution of ethyl acetate/acetonitrile, the synthesis conditions of Verdinexor are optimized, and the problems of low yield and difficulty in purification in the prior art are solved, and the synthesis of Verdinexor with high efficiency and high purity is achieved, which is suitable for industrial production.

CN116514773BActive Publication Date: 2024-12-03CHONGQING HANPEI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310449951.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-04-24
Publication Date
2024-12-03
Estimated Expiration
2043-04-24

AI Technical Summary

Technical Problem

The existing Verdinexor (KPT-335) synthesis method has low reaction yield, harsh conditions, easy to produce impurities, difficult purification, and is not suitable for large-scale production.

Method used

(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole-1-yl)acrylic acid and 2-hydrazine pyridine in 1- Ethyl-(3-dimethylaminopropyl)carboyldiimide hydrochloride acts on the ethyl acetate/acetonitrile mixed solution for acylation, and the reaction conditions are optimized to improve yield and purity.

Benefits of technology

The efficient synthesis of Verdinexor is achieved, with a yield of 86%, high purity and mild conditions, suitable for industrial production, and further improved the stability and production efficiency of the product through hydrochloride synthesis method.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004197125530000021
    Figure BDA0004197125530000021
  • Figure BDA0004197125530000031
    Figure BDA0004197125530000031
  • Figure BDA0004197125530000041
    Figure BDA0004197125530000041
Patent Text Reader

Abstract

The invention discloses a synthesis method of Verdinexor (KPT-335) and its hydrochloride, and the steps are as follows: methyl propiolate and sodium iodide are reacted to generate compound I through addition reaction; 3,5-bis-trifluoromethylbenzonitrile reacts with sodium hydrosulfide under the action of magnesium chloride to generate compound II; compound II reacts with hydrazine hydrate and formic acid in a reaction solvent to generate compound III; compound III reacts with compound I in a reaction solvent under the action of potassium carbonate and triethylenediamine to generate compound IV; compound IV reacts with lithium hydroxide in a reaction reagent to generate compound V; compound V reacts with 2-hydrazine pyridine in a reaction solvent under the action of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride to generate Verdinexor (KPT-335) VI and finally forms salt. The route reaction is simple in treatment, mild in reaction conditions, less isomers are generated, high in yield, high in purity, simple in process, and suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of organic synthesis, and in particular to a method for synthesizing Verdinexor (KPT-335) and its hydrochloride. Background Art

[0002] The chemical name of Verdinexor (KPT-335) is (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide.

[0003] Verdinexor (KPT-335) is a potent and selective inhibitor of nuclear export. Nuclear export (SINE) is mainly mediated by exportin 1 (XPO1), which can mediate the transport of specific proteins out of the nucleus and play an important role in regulating proliferation and cell cycle.

[0004] Verdinexor(KPT-335) is a potent and selective SINE inhibitor that can be used as an antiviral agent. In A549 cells inoculated with influenza A and B viruses, verdinexor effectively inhibited the replication of influenza A and B virus strains. Verdinexor(1M) can lead to the accumulation of vRNPs in the nucleus and alter the localization of viral NS1. In addition, verdinexor can increase the antisense vRNA in the nucleus by 56.6 times and significantly reduce the antisense vRNA in the cytoplasm, indicating that verdinexor can block the nuclear export of vRNPs. In 293T cells, verdinexor inhibits XPO1-NEP binding.

[0005] In mice infected with influenza A virus, verdinexor significantly reduced influenza A virus titers in the lungs. Verdinexor also reduced the expression of the proinflammatory cytokines tumor necrosis factor alpha, interleukin 6, interleukin 1 beta, and interferon gamma. In mice infected with lethal doses, verdinexor inhibited viral respiratory entry and viral spread in the lungs. In companion dogs with B and T cell lymphomas, verdinexor had potent cytotoxic activity.

[0006] At present, WO 2013 / 019548 Al discloses a method for synthesizing Verdinexor (KPT-335), which mainly involves the acylation reaction of (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid and 2-hydrazinepyridine promoted by 1-propylphosphoric acid cyclic anhydride. The disadvantages are: low reaction yield (only 29%), harsh conditions, easy generation of impurities during the reaction, difficult purification, and not conducive to large-scale production. Summary of the invention

[0007] In view of the problems of the prior art, the first purpose of the present invention is to provide a method for synthesizing Verdinexor (KPT-335), and the second purpose is to provide a method for synthesizing Verdinexor (KPT-335) hydrochloride, which has short reaction time, high efficiency, high yield and purity of the product, mild reaction conditions, no corrosion to equipment, and is suitable for industrial production.

[0008] To achieve the above first object, the present invention is implemented by the following technical scheme: a method for synthesizing Verdinexor (KPT-335), characterized in that: (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid and 2-hydrazinepyridine are subjected to acylation reaction in an ethyl acetate / acetonitrile mixed solution under the action of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to obtain (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide (Verdinexor), and the reaction formula thereof is shown below:

[0009]

[0010] In the above scheme: the volume ratio of ethyl acetate:acetonitrile is 16-18:11-13, and the reaction temperature is about 0°C;

[0011] Calculated in molar ratio, (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid:2-hydrazinepyridine:1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride is 1:1.05-1.2:1.4-1.6.

[0012] The specific operation process is as follows: (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid is dissolved in a mixed solution of ethyl acetate / acetonitrile, 2-hydrazinepyridine is added, and the mixture is cooled to 0°C. At this temperature, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride is added, and the reaction is stirred until the reaction is completed. Water is added, and the mixture is stirred at room temperature. The organic phase is separated and collected, and the organic phase is washed with saturated NaHCO3 aqueous solution and water, respectively. The organic phase is dried over anhydrous sodium sulfate and then filtered. The solvent is evaporated under reduced pressure, and the product is recrystallized with n-hexane / ethyl acetate. The product is filtered and dried in vacuum (-0.1MPa) to obtain a white solid.

[0013] The present invention optimizes the step and uses n-hexane and ethyl acetate as a mixed solvent, so that the reaction can be carried out at 0°C. Compared with -40°C, the operation is easier, the energy consumption is lower, and the reaction conditions are mild. At the same time, the organic solvent is replaced with ethyl acetate / acetonitrile for easy mixing, and the yield of the whole reaction process can reach 86%.

[0014] The second object of the present invention is achieved by: a method for synthesizing Verdinexor (KPT-335) hydrochloride, characterized in that it comprises the following steps:

[0015] (1) Methyl propiolate and sodium iodide are subjected to an addition reaction in the presence of acetic acid to obtain (Z)-3-iodoacrylate methyl ester, the reaction formula of which is shown below:

[0016]

[0017] (2) 3,5-bis(trifluoromethyl)benzonitrile and sodium hydrosulfide react under the action of magnesium chloride to obtain 3,5-bis(trifluoromethyl)thiobenzamide, the reaction formula of which is shown below:

[0018]

[0019] (3) 3,5-bis(trifluoromethyl)thiobenzamide undergoes a cyclization reaction with hydrazine hydrate and formic acid to obtain 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole. The cyclization reaction formula is shown below:

[0020]

[0021] (4) 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole and (Z)-3-iodoacrylate methyl ester undergo nucleophilic substitution reaction in the presence of potassium carbonate and triethylenediamine to obtain (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate methyl ester. The reaction formula is shown below:

[0022]

[0023] (5) Methyl (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate is hydrolyzed with lithium hydroxide in a mixed solution of water / methanol / tetrahydrofuran to obtain (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid, and the reaction formula is as follows:

[0024]

[0025] (6) (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid and 2-hydrazinepyridine undergo acylation reaction in an ethyl acetate / acetonitrile mixed solution under the action of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to obtain (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide (Verdinexor), and the reaction formula is shown below:

[0026]

[0027] (7) (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide (Verdinexor) reacts with hydrochloric acid to obtain Verdinexor (KPT-335) hydrochloride, and the reaction formula is as follows:

[0028]

[0029] In the above scheme: the temperature of the addition reaction process in step (1) is controlled at 70°C-80°C,

[0030] Calculated by molar ratio, methyl propiolate: sodium iodide is 1:1.1-1.6, and the amount of acetic acid is 4-6mL:1g according to acetic acid: methyl propiolate.

[0031] The specific operation of step (1) is as follows: sodium iodide is dissolved in acetic acid, methyl propiolate is added dropwise to the mixture at 0°C, and then reacted at 70°C for 24 hours. After the reaction is completed, the mixture is cooled to room temperature, diluted with water, extracted with ethyl acetate, the organic phases are combined, washed with 3M potassium hydroxide aqueous solution, washed with saturated Na2S2O3 aqueous solution, washed with brine, dried with anhydrous sodium sulfate, filtered, and ethyl acetate is evaporated under reduced pressure to obtain liquid compound I.

[0032] In the above scheme: the reaction solvent used in step (2) is N,N-dimethylformamide, and the reaction is carried out at room temperature; calculated by mass ratio, 3,5-bistrifluoromethylbenzonitrile: sodium hydrosulfide: magnesium chloride is 1:0.6-0.7:0.9-1.0.

[0033] The specific operation of step (2) is as follows: 3,5-bis(trifluoromethyl)benzonitrile is dissolved in N,N-dimethylformamide, sodium hydrosulfide and magnesium chloride are added, and the mixture is stirred at 25° C. After the reaction is completed, the reaction mixture is poured into ice, extracted with ethyl acetate, the organic phases are combined, washed three times with brine, dried with anhydrous sodium sulfate, filtered, ethyl acetate is evaporated under reduced pressure, and dried in vacuo to obtain a yellow solid compound II.

[0034] In the above scheme: the solvent used for the cyclization reaction in step (3) is N,N-dimethylformamide, and the reaction process is first reacted at room temperature for 0.5-1.5h, and then the temperature is raised to reflux reaction until the reaction is complete;

[0035] Calculated in molar ratio, the ratio of 3,5-bis(trifluoromethyl)thiobenzamide to hydrazine hydrate is 1:2-3, the amount of formic acid used is 0.47-0.6 mL:1 g based on formic acid:3,5-bis(trifluoromethyl)thiobenzamide, and the amount of N,N-dimethylformamide used is 4-6 mL:1 g based on N,N-dimethylformamide:3,5-bis(trifluoromethyl)thiobenzamide.

[0036] In the above scheme: the specific operation of step (3) is: adding 3,5-bis(trifluoromethyl)thiobenzamide to N,N-dimethylformamide, and controlling the temperature below 25°C, adding hydrazine hydrate dropwise, and then stirring at room temperature for reaction, and then adding formic acid dropwise. After the addition is complete, the temperature is raised to reflux for reaction. After the reaction is completed, the reaction solution is cooled to room temperature, poured into a saturated sodium bicarbonate aqueous solution, stirred, and saturated sodium bicarbonate is added until no bubbles are generated, extracted with ethyl acetate, and the organic phase is washed, dried, filtered, and ethyl acetate is evaporated under reduced pressure, and then stirred and washed with a mixed solution of n-hexane / ethyl acetate, filtered, and vacuum dried to obtain 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole.

[0037] In the above scheme: in the reaction in step (4), the solvent used is acetonitrile, and the reaction process is first controlled at room temperature for 0.5 h, and then cooled to 0°C to react until the reaction is complete;

[0038] Calculated by molar ratio, 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole:(Z)-3-iodoacrylate methyl ester:anhydrous potassium carbonate:triethylenediamine is 1:1.5-2:1.5-2:1.5-2;

[0039] The specific operation method is: dissolve 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole in acetonitrile, add anhydrous potassium carbonate, stir and react at room temperature for half an hour, then add triethylenediamine, and cool to 0°C within 25 minutes, then dissolve (Z)-3-iodoacrylate methyl ester in acetonitrile, and add the solution dropwise to the reaction mixture, maintain the temperature at 0°C for reaction, after the reaction is completed, add water, and stir at 0°C, filter the solid, wash with water, then, wash the obtained white solid with a cyclohexane / ethyl acetate mixed solution, filter, rinse with cyclohexane, and dry in vacuum (-0.1MPa).

[0040] In the above scheme: in the reaction in step (5), the volume ratio of the mixed solution of water / methanol / tetrahydrofuran is 145:73:44, and the reaction is carried out at room temperature;

[0041] Calculated in molar ratio, (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate:lithium hydroxide is 1:7-8.

[0042] The specific operation of step (5) is as follows: Compound IV is dissolved in a mixed solution of water / methanol / tetrahydrofuran, anhydrous lithium hydroxide is added, and the mixture is stirred at 25° C. After the reaction is completed, water is added to dilute the reactant, and the pH is slowly adjusted to 2 with HCl, and then stirred at 25° C., the product is filtered, rinsed with water, and vacuum dried at 55° C. to obtain a white solid compound V.

[0043] In the above scheme: the reaction solvent used in step (7) is ether, and the reaction is carried out at room temperature;

[0044] The hydrochloric acid used was a 4 M solution of hydrogen chloride in 1,4-dioxane.

[0045] The specific operation is as follows: Compound VI is dissolved in ether and cooled to 0°C, 4M hydrogen chloride 1,4-dioxane solution is added at this temperature, and the reaction is stirred at room temperature for 1 hour. After the reaction is completed, the product is filtered, washed with ether, rinsed with ethyl acetate / n-hexane (2 / 1), and vacuum dried to obtain a white solid Verdinexor (KPT-335) hydrochloride VII.

[0046] Compared with the prior art, the present invention has the following advantages:

[0047] 1. The Verdinexor (KPT-335) hydrochloride synthesis method of the present invention has high reaction efficiency, a simple purification method, and convenient and safe operation, and is suitable for large-scale industrial production of Verdinexor (KPT-335) hydrochloride.

[0048] 2. The Verdinexor (KPT-335) hydrochloride synthesis method of the present invention uses simple and readily available raw materials and does not require the use of hazardous chemicals, thus causing little environmental pollution.

[0049] 3. The Verdinexor prepared by the method of the present invention has high purity, mild reaction conditions, is non-corrosive to equipment, and is suitable for industrial production. DETAILED DESCRIPTION

[0050] The present invention will be further described below in conjunction with embodiments.

[0051] The synthetic route of the synthetic method of Verdinexor (KPT-335) hydrochloride of the present invention is as follows:

[0052]

[0053] Example 1

[0054] Synthesis of Compound Ⅰ

[0055] 23.5g sodium iodide (149.86, 1.573mol) was dissolved in 46mL acetic acid, 12.0g methyl propiolate (84.07, 1.43mol) was added dropwise to the mixture at 0°C, and then reacted at 70°C-80°C for 24h. After the reaction, the mixture was cooled to room temperature, diluted with 100mL water, extracted with ethyl acetate (100mL×3), the organic phases were combined, washed with 3M potassium hydroxide aqueous solution (250mL), washed with saturated Na2S2O3 aqueous solution, washed with brine, dried with anhydrous sodium sulfate, filtered, and ethyl acetate was evaporated under reduced pressure to obtain 27.3g of liquid compound I with a yield of 90%. H NMR characterization data: 1 H NMR (400MHz, CDCl3) δ7.50 (d, J = 9.0 Hz, 1H), 6.93 (d, J = 9.0 Hz, 1H), 3.79 (s, 3H).

[0056] Example 2

[0057] Synthesis of Compound Ⅰ

[0058] 25.7g sodium iodide (149.86, 1.573mol) was dissolved in 57mL acetic acid, 12.0g propiolic acid methyl ester (84.07, 1.43mol) was added dropwise to the mixture at 0°C, and then reacted at 70°C-80°C for 24h. After the reaction, the mixture was cooled to room temperature, diluted with 100mL water, extracted with ethyl acetate (100mL×3), the organic phases were combined, washed with 3M potassium hydroxide aqueous solution (250mL), washed with saturated Na2S2O3 aqueous solution, washed with brine, dried with anhydrous sodium sulfate, filtered, and ethyl acetate was evaporated under reduced pressure to obtain 27.9g of liquid compound I with a yield of 91.7%. H-NMR characterization data: 1 H NMR (400MHz, CDCl3) δ7.50 (d, J = 9.0 Hz, 1H), 6.93 (d, J = 9.0 Hz, 1H), 3.79 (s, 3H).

[0059] Example 3

[0060] Synthesis of Compound Ⅱ

[0061] Dissolve 12g of 3,5-bis(trifluoromethyl)benzonitrile in 60mL of N,N-dimethylformamide, add 7.4g of sodium hydrosulfide and 11.2g of magnesium chloride, and stir at 25°C for 5h. After the reaction, pour the reaction mixture into ice, extract with ethyl acetate (100mL×3), combine the organic phases, wash three times with brine, dry with anhydrous sodium sulfate, filter, evaporate ethyl acetate under reduced pressure, and dry under vacuum (-0.1MPa) to obtain 13.1g of yellow solid compound II, with a yield of 95.5%. H-NMR characterization data: 1 H NMR (400MHz, CDCl3) δ8.28(s,2H),8.00(s,1H),7.92(s,1H),7.28(s,1H).

[0062] Example 4

[0063] Synthesis of Compound Ⅱ

[0064] Dissolve 12g of 3,5-bis(trifluoromethyl)benzonitrile in 60mL of N,N-dimethylformamide, add 8.4g of sodium hydrosulfide and 12g of magnesium chloride, and stir at 25°C for 5h. After the reaction, pour the reaction mixture into ice, extract with ethyl acetate (100mL×3), combine the organic phases, wash three times with brine, dry with anhydrous sodium sulfate, filter, evaporate ethyl acetate under reduced pressure, and dry under vacuum (-0.1MPa) to obtain 12.6g of yellow solid compound II, with a yield of 91.8%. H-NMR characterization data: 1 H NMR (400MHz, CDCl3) δ8.28(s,2H),8.00(s,1H),7.92(s,1H),7.28(s,1H).

[0065] Example 5

[0066] Synthesis of Compound III

[0067] 30g of compound II was dissolved in 140mL of N,N-dimethylformamide, and 13.8g of 80% hydrazine hydrate (2eq) was slowly added dropwise at 25°C. After the addition was completed, the mixture was stirred and reacted at room temperature for 1 hour. Then 14mL of formic acid was added dropwise to the mixture, and the reaction mixture was placed at 90°C for reflux reaction for 5h. After the reaction was completed, it was cooled to room temperature, the reaction mixture was poured into a saturated sodium bicarbonate aqueous solution, stirred and added with a saturated sodium bicarbonate aqueous solution until no bubbles were generated, extracted with ethyl acetate three times, the organic phases were combined, washed with brine three times, dried with anhydrous sodium sulfate, filtered, ethyl acetate was evaporated under reduced pressure, and washed with 120mL of a mixed solution of n-hexane / ethyl acetate (5 / 1), and dried under vacuum (-0.1MPa) to obtain a solid compound III (25.7g, yield 83.2%). Nuclear magnetic hydrogen spectrum characterization data: 1H NMR (400MHz, CDCl3) δ8.70 (s, 1H), 8.49 (s, 2H), 8.08 (s, 1H).

[0068] Example 6

[0069] Synthesis of Compound III

[0070] Dissolve 30g of compound II in 120mL N,N-dimethylformamide, and slowly add 20.7g of 80% hydrazine hydrate at 25°C. After the addition, stir and react at room temperature for 1.5 hours. Then add 18mL of formic acid to the mixture, and place the reaction mixture under reflux at 90°C for 5h. After the reaction is completed, cool to room temperature, pour the reaction mixture into a saturated sodium bicarbonate aqueous solution, stir and add a saturated sodium bicarbonate aqueous solution until no bubbles are generated, extract with ethyl acetate three times, combine the organic phases, wash with brine three times, dry with anhydrous sodium sulfate and filter, remove ethyl acetate under reduced pressure, stir and wash with 120mL of a mixed solution of n-hexane / ethyl acetate (5 / 1), further remove impurities, and dry in vacuum (-0.1MPa) to obtain solid compound III (26.1g, yield 84.5%). H NMR characterization data: 1 H NMR (400MHz, CDCl3) δ8.70(s,1H),8.49(s,2H),8.08(s,1H).

[0071] Example 7

[0072] Synthesis of Compound IV

[0073] 26g of compound III (1eq) was dissolved in 200mL of acetonitrile, 19.18g of anhydrous potassium carbonate (1.5eq) was added, and the reaction was stirred at 25°C for half an hour, and then 15.56g of triethylenediamine (1.5eq) was added, and the reaction was cooled to 0°C within 25min. Then, 29.41g of (Z)-3-iodoacrylate (1.5eq) was dissolved in 50mL of acetonitrile, and the solution was added dropwise to the reaction mixture, the temperature was maintained at 0°C for reaction, and the reaction was detected by TLC. After the reaction was completed, 250mL of water was added, and the mixture was stirred at 0°C for 1h, the solid was filtered, and the solid was washed with water. Then, the obtained white solid was stirred and washed with 220mL of cyclohexane / ethyl acetate (10 / 1) mixed solution, filtered, rinsed with cyclohexane, and dried in vacuum (-0.1MPa) to obtain a white solid compound IV (compound 28.7g, yield 85%). Its nuclear magnetic hydrogen spectrum characterization data: 1 H NMR (400MHz, CDCl3) δ9.75 (s, 1H), 8.60 (s, 2H), 7.93 (s, 1H), 7.31 (d, J = 10.9Hz, 1H), 5.79 (d, J = 10.9Hz, 1H), 3, 84 (s, 3H).

[0074] Example 7

[0075] Synthesis of Compound IV

[0076] 26g of compound III (1eq) was dissolved in 200mL of acetonitrile, 25.57g of anhydrous potassium carbonate (2eq) was added, and the mixture was stirred at 25°C for half an hour, and then 20.74g of triethylenediamine (2eq) was added, and the mixture was cooled to 0°C within 25min. Then, 39.21g of (Z)-3-iodoacrylate (2eq) was dissolved in 60mL of acetonitrile, and the solution was added dropwise to the reaction mixture, and the temperature was maintained at 0°C for reaction, and the reaction was detected by TLC. After the reaction was completed, 250mL of water was added, and the mixture was stirred at 0°C for 1h, the solid was filtered, and the solid was washed with water. Then, the obtained white solid was stirred and washed with 220mL of cyclohexane / ethyl acetate (10 / 1) mixed solution, filtered, washed with cyclohexane, and dried under vacuum (-0.1MPa) to obtain 28.5g of white solid compound IV, with a yield of 84.4%. Its nuclear magnetic hydrogen spectrum characterization data: 1 H NMR (400MHz, CDCl3) δ9.75 (s, 1H), 8.60 (s, 2H), 7.93 (s, 1H), 7.31 (d, J = 10.9Hz, 1H), 5.79 (d, J = 10.9Hz, 1H), 3, 84 (s, 3H).

[0077] Example 8

[0078] Synthesis of Compound Ⅴ

[0079] 28.7g of compound IV (1eq) was dissolved in 262mL of a mixed solution of water / methanol / tetrahydrofuran (145 / 73 / 44), 13.28g of anhydrous lithium hydroxide (7eq) was added, and the mixture was stirred at 25°C for 2 hours. After the reaction was completed, 145mL of water was added to dilute the reactant, and the pH was slowly adjusted to 2 with HCl, and then stirred at 25°C for 1h, the product was filtered, rinsed with water, and dried at 55°C under vacuum (-0.1MPa) for 8h. The white solid compound V was dried under vacuum (-0.1MPa) to obtain 25.43g of compound V, with a yield of 92.1%. Compound V is (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid, and its nuclear magnetic hydrogen spectrum characterization data are as follows: 1 H NMR (400MHz, DMSO-d6) δ9.36 (s, 1H), 8.52 (s, 2H), 8.27 (s, 1H), 7.49 (d, J = 10.2Hz, 1H), 5.98 (d, J = 10.2Hz, 1H).

[0080] Example 9

[0081] Synthesis of Compound Ⅴ

[0082] 28.7g of compound IV (1eq) was dissolved in 262mL of a mixed solution of water / methanol / tetrahydrofuran (145 / 73 / 44), 15.17g of anhydrous lithium hydroxide (8eq) was added, and the mixture was stirred at 25°C for 2 hours. After the reaction was completed, 145mL of water was added to dilute the reactant, and the pH was slowly adjusted to 2 with HCl, and then stirred at 25°C for 1h, the product was filtered, rinsed with water, and dried at 55°C under vacuum (-0.1MPa) for 8h. The white solid compound V was dried under vacuum (-0.1MPa) to obtain 25.48g of the compound V, with a yield of 92.3%. Compound V is (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid, and its nuclear magnetic hydrogen spectrum characterization data are as follows: 1 H NMR (400MHz, DMSO-d6) δ9.36 (s, 1H), 8.52 (s, 2H), 8.27 (s, 1H), 7.49 (d, J = 10.2Hz, 1H), 5.98 (d, J = 10.2Hz, 1H).

[0083] Example 10

[0084] Synthesis of Compound Ⅴ

[0085] 28.7g of compound IV (1eq) was dissolved in a mixed solution of 262mL of water / tetrahydrofuran (145 / 44), 15.17g of anhydrous lithium hydroxide (8eq) was added, and the mixture was stirred at 25°C for 2 hours. After the reaction was completed, 145mL of water was added to dilute the reactant, and HCl was slowly used to adjust the pH to 2, and then stirred at 25°C for 1h, the product was filtered, rinsed with water, and dried at 55°C under vacuum (-0.1MPa) for 8h. The white solid compound V was dried under vacuum (-0.1MPa) to obtain 19.87g of compound V, with a yield of 72%. Compound V is (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid, and its nuclear magnetic hydrogen spectrum characterization data are as follows: 1 H NMR (400MHz, DMSO-d6) δ9.36 (s, 1H), 8.52 (s, 2H), 8.27 (s, 1H), 7.49 (d, J = 10.2Hz, 1H), 5.98 (d, J = 10.2Hz, 1H).

[0086] Embodiment 11

[0087] Synthesis of Compound Ⅴ

[0088] 28.7g of compound IV (1eq) was dissolved in a mixed solution of 262mL of water / methanol (145 / 73), 15.17g of anhydrous lithium hydroxide (8eq) was added, and the mixture was stirred at 25°C for 2 hours. After the reaction was completed, 145mL of water was added to dilute the reactant, and the pH was slowly adjusted to 2 with HCl at a dilution ratio of 1:1, and then stirred at 25°C for 1h, the product was filtered, rinsed with water, and dried at 55°C under vacuum (-0.1MPa) for 8h. The white solid compound V was dried under vacuum (-0.1MPa) to obtain 17.5g of compound V, with a yield of 63.3%. Compound V is (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid, and its nuclear magnetic hydrogen spectrum characterization data are as follows: 1 H NMR (400MHz, DMSO-d6) δ9.36 (s, 1H), 8.52 (s, 2H), 8.27 (s, 1H), 7.49 (d, J = 10.2Hz, 1H), 5.98 (d, J = 10.2Hz, 1H).

[0089] Example 12

[0090] Synthesis of Compound VI

[0091] 24.5g of compound V (1eq) was dissolved in 290mL of ethyl acetate / acetonitrile (17 / 12) mixed solution, 8.05g of 2-hydrazinepyridine (1.05eq) was added, and the mixture was cooled to 0°C. At this temperature, 20.13g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.5eq) was added, and the mixture was stirred for 3 hours. After the reaction was completed, 80mL of water was added, and the mixture was stirred at room temperature for 15min. The organic phase was separated and collected, and the organic phase was washed with saturated NaHCO3 aqueous solution and water, respectively, and the organic phase was dried over anhydrous sodium sulfate and filtered. The solvent was evaporated under reduced pressure, and the mixture was recrystallized with n-hexane / ethyl acetate (volume ratio 5 / 1). The product was filtered and dried under vacuum (-0.1MPa) to obtain 26.66g of white solid compound VI with a yield of 86%. Compound VI (Verdinexor) is (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide, and its H NMR characterization data are as follows: 1 HNMR(400MHz,DMSO-d6)δ10.41(s,1H),9.66(s,1H),8.58(s,1H),8.52(s,2H),8.26(s,1H),8.08(d,J=6 .0Hz,1H),7.55–7.45(m,2H),6.73(dd,J=7.2,5.0Hz,1H),6.68(d,J=8.4Hz,1H),6.09(d,J=10.5Hz,1H).

[0092] Example 13

[0093] Synthesis of Compound VI

[0094] 24.5g of compound V (1eq) was dissolved in 290mL of ethyl acetate / acetonitrile (17 / 12) mixed solution, 9.2g of 2-hydrazinepyridine (1.2eq) was added, and the mixture was cooled to 0°C. At this temperature, 21.47g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.6eq) was added, and the mixture was stirred for 3 hours. After the reaction was completed, 90mL of water was added, and the mixture was stirred at room temperature for 15min. The organic phase was separated and collected, and the organic phase was washed with saturated NaHCO3 aqueous solution and water, respectively, and the organic phase was dried over anhydrous sodium sulfate and filtered. The solvent was evaporated under reduced pressure, and the mixture was recrystallized with n-hexane / ethyl acetate (volume ratio 5 / 1). The product was filtered and dried under vacuum (-0.1MPa) to obtain 25.86g of white solid compound VI with a yield of 83.4%. Compound VI (Verdinexor) is (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide, and its H NMR characterization data are as follows: 1H NMR (400MHz, DMSO-d6) δ10.41(s,1H),9.66(s,1H),8.58(s,1H),8.52(s,2H),8.26(s,1H),8.08(d,J=6. 0Hz,1H),7.55–7.45(m,2H),6.73(dd,J=7.2,5.0Hz,1H),6.68(d,J=8.4Hz,1H),6.09(d,J=10.5Hz,1H).

[0095] Embodiment 15

[0096] Synthesis of Compound VI

[0097] 24.5g of compound V (1eq) was dissolved in 290mL of ethyl acetate / acetonitrile (16 / 11) mixed solution, 9.2g of 2-hydrazinepyridine (1.2eq) was added, and the mixture was cooled to 0°C. At this temperature, 21.47g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.6eq) was added, and the mixture was stirred for 3 hours. After the reaction was completed, 90mL of water was added, and the mixture was stirred at room temperature for 15min. The organic phase was separated and collected, and the organic phase was washed with saturated NaHCO3 aqueous solution and water, respectively, and the organic phase was dried over anhydrous sodium sulfate and filtered. The solvent was evaporated under reduced pressure, and the mixture was recrystallized with n-hexane / ethyl acetate (volume ratio 5 / 1). The product was filtered and dried under vacuum (-0.1MPa) to obtain 26.6g of white solid compound VI with a yield of 85.8%. Compound VI (Verdinexor) is (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide, and its H NMR characterization data are as follows: 1 HNMR(400MHz,DMSO-d6)δ10.41(s,1H),9.66(s,1H),8.58(s,1H),8.52(s,2H),8.26(s,1H),8.08(d,J=6 .0Hz,1H),7.55–7.45(m,2H),6.73(dd,J=7.2,5.0Hz,1H),6.68(d,J=8.4Hz,1H),6.09(d,J=10.5Hz,1H).

[0098] Example 16

[0099] Synthesis of Compound VI

[0100] 24.5g of compound V (1eq) was dissolved in 290mL of ethyl acetate / acetonitrile (18 / 13) mixed solution, 9.2g of 2-hydrazinepyridine (1.2eq) was added, and the mixture was cooled to 0°C. At this temperature, 21.47g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.6eq) was added, and the mixture was stirred for 3 hours. After the reaction was completed, 90mL of water was added, and the mixture was stirred at room temperature for 15min. The organic phase was separated and collected, and the organic phase was washed with saturated NaHCO3 aqueous solution and water, respectively, and the organic phase was dried over anhydrous sodium sulfate and filtered. The solvent was evaporated under reduced pressure, and the mixture was recrystallized with n-hexane / ethyl acetate (volume ratio 5 / 1). The product was filtered and dried under vacuum (-0.1MPa) to obtain 26.3g of white solid compound VI with a yield of 84.9%. Compound VI (Verdinexor) is (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide, and its H NMR characterization data are as follows: 1 HNMR(400MHz,DMSO-d6)δ10.41(s,1H),9.66(s,1H),8.58(s,1H),8.52(s,2H),8.26(s,1H),8.08(d,J=6 .0Hz,1H),7.55–7.45(m,2H),6.73(dd,J=7.2,5.0Hz,1H),6.68(d,J=8.4Hz,1H),6.09(d,J=10.5Hz,1H).

[0101] Embodiment 17

[0102] Synthesis of Compound VI

[0103] 24.5g of compound V (1eq) was dissolved in 290mL of ethyl acetate / dichloromethane (17 / 12) mixed solution, 8.05g of 2-hydrazinepyridine (1.05eq) was added, and the mixture was cooled to 0°C. At this temperature, 20.13g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.5eq) was added, and the mixture was stirred for 3 hours. After the reaction was completed, 80mL of water was added, and the mixture was stirred at room temperature for 15min. The organic phase was separated and collected, and the organic phase was washed with saturated NaHCO3 aqueous solution and water, respectively, and the organic phase was dried over anhydrous sodium sulfate and filtered. The solvent was evaporated under reduced pressure, and the mixture was recrystallized with n-hexane / ethyl acetate (volume ratio 5 / 1). The product was filtered and dried under vacuum (-0.1MPa) to obtain 13.52g of white solid compound VI with a yield of 43.6%. Compound VI (Verdinexor) is (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide, and its H NMR characterization data are as follows: 1H NMR (400MHz, DMSO-d6) δ10.41(s,1H),9.66(s,1H),8.58(s,1H),8.52(s,2H),8.26(s,1H),8.08(d,J=6. 0Hz,1H),7.55–7.45(m,2H),6.73(dd,J=7.2,5.0Hz,1H),6.68(d,J=8.4Hz,1H),6.09(d,J=10.5Hz,1H).

[0104] Embodiment 18

[0105] Synthesis of Compound VI

[0106] 24.5g of compound V (1eq) was dissolved in 290mL of ethyl acetate / THF (17 / 12) mixed solution, 8.05g of 2-hydrazinepyridine (1.05eq) was added, and the mixture was cooled to 0°C. At this temperature, 20.13g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.5eq) was added, and the mixture was stirred for 3 hours. After the reaction was completed, 80mL of water was added, and the mixture was stirred at room temperature for 15min. The organic phase was separated and collected, and the organic phase was washed with saturated NaHCO3 aqueous solution and water, respectively, and the organic phase was dried over anhydrous sodium sulfate and filtered. The solvent was evaporated under reduced pressure, and the mixture was recrystallized with n-hexane / ethyl acetate (volume ratio 5 / 1). The product was filtered and dried under vacuum (-0.1MPa) to obtain 10.4g of white solid compound VI with a yield of 33.6%. Compound VI (Verdinexor) is (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide, and its H NMR characterization data are as follows: 1 HNMR(400MHz,DMSO-d6)δ10.41(s,1H),9.66(s,1H),8.58(s,1H),8.52(s,2H),8.26(s,1H),8.08(d,J=6 .0Hz,1H),7.55–7.45(m,2H),6.73(dd,J=7.2,5.0Hz,1H),6.68(d,J=8.4Hz,1H),6.09(d,J=10.5Hz,1H).

[0107] Embodiment 18

[0108] 11g of compound VI was dissolved in 400mL of ether and cooled to 0°C. 16mL of 4M hydrogen chloride 1,4-dioxane solution was added at this temperature and stirred at room temperature for 1 hour. After the reaction, the product was filtered, washed with ether, rinsed with ethyl acetate / n-hexane (2 / 1), and dried under vacuum (-0.1MPa) to obtain 11.4g of white solid Verdinexor (KPT-335) hydrochloride VII compound, with a yield of 95% and a purity of 99.58%.

[0109] H NMR spectrum characterization data: 1 H NMR (400MHz, DMSO-d6) δ11.21(s,1H),10.80(s,1H),9.55(s,1H),8.54(s,2H),8.29(s,1H),8.05(dd,J=13. 4,7.0Hz,2H),7.61(d,J=10.4Hz,1H),7.21(d,J=8.9Hz,1H),7.07(t,J=6.6Hz,1H),6.17(d,J=10.4Hz,1H).

[0110] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A method for synthesizing Verdinexor (KPT-335) hydrochloride, characterized in that: The following steps are involved: (1) Methyl propiolate and sodium iodide are subjected to an addition reaction in the presence of acetic acid to obtain (Z)-3-iodoacrylate methyl ester, the reaction formula of which is shown below: (2) 3,5-bis(trifluoromethyl)benzonitrile and sodium hydrosulfide react under the action of magnesium chloride to obtain 3,5-bis(trifluoromethyl)thiobenzamide, the reaction formula of which is shown below: (3) 3,5-bis(trifluoromethyl)thiobenzamide undergoes a cyclization reaction with hydrazine hydrate and formic acid to obtain 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole. The cyclization reaction formula is shown below: (4) 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole and (Z)-3-iodoacrylate methyl ester undergo nucleophilic substitution reaction in the presence of potassium carbonate and triethylenediamine to obtain (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate methyl ester. The reaction formula is shown below: (5) Methyl (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate is hydrolyzed with lithium hydroxide in a mixed solution of water / methanol / tetrahydrofuran to obtain (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid, and the reaction formula is as follows: In the reaction in step (5), the volume ratio of the mixed solution of water / methanol / tetrahydrofuran is 145:73:44, and the reaction is carried out at room temperature; Calculated by molar ratio, (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)methyl acrylate: lithium hydroxide is 1:7-8; (6) (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid and 2-hydrazinepyridine undergo acylation reaction in an ethyl acetate / acetonitrile mixed solution under the action of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to obtain (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide (Verdinexor), and the reaction formula is shown below: The volume ratio of ethyl acetate: acetonitrile is 16-18: 11-13, and the reaction temperature is 0°C; the molar ratio of (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid: 2-hydrazinepyridine: 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride is 1: 1.05-1.2: 1.4-1.6; the specific operation process is: (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4 -triazole-1-yl) acrylic acid is dissolved in an ethyl acetate / acetonitrile mixed solution, 2-hydrazine pyridine is added, and the mixture is cooled to 0°C, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride is added at this temperature, and the mixture is stirred to react until the reaction is completed, water is added, and the mixture is stirred at room temperature, and the mixture is separated, and the organic phase is collected, and the organic phase is washed with a saturated NaHCO3 aqueous solution and water, respectively, and the organic phase is dried over anhydrous sodium sulfate and then filtered, and the solvent is evaporated under reduced pressure, and the mixture is recrystallized with a n-hexane / ethyl acetate mixed solution, and the product is filtered and dried in vacuo to obtain a white solid; (7) (Z)-3(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acryloylhydrazide (Verdinexor) reacts with hydrochloric acid to obtain Verdinexor (KPT-335) hydrochloride, and the reaction formula is as follows:

2. A method for synthesizing Verdinexor (KPT-335) hydrochloride according to claim 1, characterized in that: The temperature of the addition reaction process in step (1) is controlled at 70°C-80°C. Calculated by molar ratio, methyl propiolate:sodium iodide is 1:1.1-1.2, and the amount of acetic acid is 4-6mL:1g according to acetic acid:methyl propiolate.

3. A method for synthesizing Verdinexor (KPT-335) hydrochloride according to claim 2, characterized in that: The reaction solvent used in step (2) is N,N-dimethylformamide, and the reaction is carried out at room temperature; calculated by mass ratio, 3,5-bis(trifluoromethyl)benzonitrile: sodium hydrosulfide: magnesium chloride is 1:0.6-0.7:0.9-1.

0.

4. A method for synthesizing Verdinexor (KPT-335) hydrochloride according to claim 3, characterized in that: The solvent used for the cyclization reaction in step (3) is N,N-dimethylformamide. The reaction process is first reacted at room temperature for 0.5-1.5h, and then the temperature is raised to reflux for reaction until the reaction is complete; calculated by molar ratio, 3,5-bis(trifluoromethyl)thiobenzamide: hydrazine hydrate is 1:2-3, the amount of formic acid used is 0.47-0.6mL:1g according to formic acid: 3,5-bis(trifluoromethyl)thiobenzamide, and the amount of N,N-dimethylformamide used is 4-6mL:1g according to N,N-dimethylformamide: 3,5-bis(trifluoromethyl)thiobenzamide.

5. A method for synthesizing Verdinexor (KPT-335) hydrochloride according to claim 4, characterized in that: The specific operation of step (3) is as follows: 3,5-bis(trifluoromethyl)thiobenzamide is added to N,N-dimethylformamide, and the temperature is controlled below 25° C., hydrazine hydrate is added dropwise, and then the mixture is stirred at room temperature for reaction, and then formic acid is added dropwise. After the addition is complete, the mixture is heated to reflux for reaction, and after the reaction is completed, the mixture is cooled to room temperature, and the reaction solution is poured into a saturated sodium bicarbonate aqueous solution, stirred, and saturated sodium bicarbonate is added until no bubbles are generated, and the reaction solution is extracted with ethyl acetate. The organic phase is washed, dried, filtered, and the ethyl acetate is evaporated under reduced pressure, and then washed with a mixed solution of n-hexane / ethyl acetate, filtered, and dried in vacuo to obtain 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole.

6. A method for synthesizing Verdinexor (KPT-335) hydrochloride according to claim 5, characterized in that: In the reaction of step (4), the solvent used is acetonitrile, and the reaction process is first controlled at room temperature for 0.5 h, and then cooled to 0° C. to react until the reaction is complete; Calculated by molar ratio, 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole:(Z)-3-iodoacrylate methyl ester:anhydrous potassium carbonate:triethylenediamine is 1:1.5-2:1.5-2:1.5-2; The specific operation method is: dissolve 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole in acetonitrile, add anhydrous potassium carbonate, stir and react at room temperature for half an hour, then add triethylenediamine, and cool to 0°C within 25 minutes, then dissolve (Z)-3-iodoacrylate methyl ester in acetonitrile, and add the solution dropwise to the reaction mixture, maintain the temperature at 0°C for reaction, after the reaction is completed, add water, and stir at 0°C, filter the solid, wash with water, then, wash the obtained white solid with a cyclohexane / ethyl acetate mixed solution, filter, rinse with cyclohexane, and vacuum dry.

7. A method for synthesizing Verdinexor (KPT-335) hydrochloride according to claim 6, characterized in that: The reaction solvent used in step (7) is diethyl ether, and the reaction is carried out at room temperature; the hydrochloric acid is a 4M hydrogen chloride solution in 1,4-dioxane.